Pestano Gary Anthony 4

What Happened Gary Anthony Pestano, Chief Development Officer of Biodesix (BDSX), had 1,528 restricted stock units (RSUs) convert to common shares on Feb 20, 2026 (conversion/exercise of a derivative). Some of the vested shares were automatically sold to cover taxes. Separately, Pestano sold 556 shares in an open-market transaction on Feb 23, 2026 for a total of about $7,103 (reported price $12.78 weighted average).

Key Details

• Transaction dates: Feb 20, 2026 (RSU conversion/settlement and tax withholding) and Feb 23, 2026 (open-market sale).
• Open-market sale: 556 shares at $12.78 reported (total ≈ $7,103). Footnote states sale prices for tax-withholding transactions ranged $12.58–$13.16 (weighted avg reported).
• RSU conversion: 1,528 RSUs converted to shares on Feb 20; some shares were sold automatically to cover taxes (footnotes F1, F2).
• RSU terms: These RSUs vest in four equal annual installments beginning Feb 20, 2025 and have no expiration date (F5).
• Adjustments: Share amounts reflect a one-for-twenty reverse stock split effective Sep 15, 2025 (F4).
• Shares owned after the transactions are not specified in the provided filing excerpt.
• Filing: Report filed Feb 23, 2026 covering the Feb 20, 2026 events (no late-filing flag indicated).

Context This activity reflects a routine RSU vesting event (conversion of RSUs to common stock) with automatic sales to satisfy tax withholding and an additional small open-market sale. Such sales tied to vesting and tax withholding are common and do not by themselves indicate a change in the insider’s long-term view of the company.